硝酸咪康唑结构式
|
常用名 | 硝酸咪康唑 | 英文名 | Miconazole Nitrate |
|---|---|---|---|---|
| CAS号 | 22832-87-7 | 分子量 | 479.141 | |
| 密度 | 1.451g/cm3 | 沸点 | 555.1ºC at 760 mmHg | |
| 分子式 | C18H15Cl4N3O4 | 熔点 | 170-185ºC | |
| MSDS | 中文版 美版 | 闪点 | 289.5ºC |
硝酸咪康唑用途【用途一】 为广谱抗霉菌药,治疗深部真菌感染 |
| 中文名 | 硝酸咪康唑 |
|---|---|
| 英文名 | Miconazole nitrate |
| 中文别名 | 双氯苯咪唑 | 达克宁 | 2,4-二氯苯基)-2-[(2,4-二氯苯基)甲氧基]乙基]-1H-咪唑硝酸盐 | 硝酸霉康唑 | 美康唑 | 美康唑 | (2,4-二氯苯基)-2-[(2,4-二氯苯基)甲氧基]乙基]-1H-咪唑硝酸盐 |
| 英文别名 | 更多 |
| 密度 | 1.451g/cm3 |
|---|---|
| 沸点 | 555.1ºC at 760 mmHg |
| 熔点 | 170-185ºC |
| 分子式 | C18H15Cl4N3O4 |
| 分子量 | 479.141 |
| 闪点 | 289.5ºC |
| 精确质量 | 476.981659 |
| PSA | 93.10000 |
| LogP | 6.63030 |
| InChIKey | MCCACAIVAXEFAL-UHFFFAOYSA-N |
| SMILES | Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1.O=[N+]([O-])O |
| 外观性状 | 固体;White to Almost white powder to crystal |
| 储存条件 | Store at RT |
| 水溶解性 | 水溶性:微溶;可溶于:甲醇 |
| 危害码 (欧洲) | Xn:Harmful |
|---|---|
| 风险声明 (欧洲) | R22;R43 |
| 安全声明 (欧洲) | S36/37 |
| 危险品运输编码 | 3249 |
| WGK德国 | 3 |
| RTECS号 | NI4771000 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
| 海关编码 | 2933990090 |
|
HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin.
J. Chromatogr. Sci. 50(10) , 855-61, (2012) High-performance liquid chromatography (HPLC) and chemometric methods were applied to the simultaneous determination of the two nonsteroidal antifungal drugs, miconazole (MIC) and nystatin (NYS). The ... |
|
|
Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin.
J. Appl. Oral Sci. 20(6) , 607-12, (2012) In order to prolong the clinical longevity of resilient denture relining materials and reduce plaque accumulation, incorporation of antimicrobial agents into these materials has been proposed. However... |
|
|
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Cochrane Database Syst. Rev. 3 , CD003478, (2013) Invasive fungal infection is an important cause of mortality and morbidity in very preterm or very low birth weight infants. Uncertainty exists about the effect of prophylactic oral/topical non-absorb... |
| Salpetersäure--1-{2-[(2,4-dichlorbenzyl)oxy]-2-(2,4-dichlorphenyl)ethyl}-1H-imidazol(1:1) |
| Hi-Pick |
| 1-[2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Nitrate |
| Miconal |
| Ecobi |
| 1-{2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole nitrate |
| 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophényl)éthyl}-1H-imidazole nitrate |
| Daktar |
| Vodol |
| 1-(2,4-Dichloro-β-[(2,4-dichlorobenzyl)oxy]phenethyl)imidazole |
| Miconazole Nitrate |
| EINECS 245-256-6 |
| Brentan |
| Aflorix |
| 1-{2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole nitrate (1:1) |
| Monistat |
| Micatin |
| 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-, nitrate (1:1) |
| monistat-Derm |
| Florid |
| MFCD00058161 |
| Micotef |
| Zeasorb-AF powder |
| Miconazole (nitrate) |